MATTO

Submission of Presenter and Exhibitor Applications is now open.

The Early-Stage Life Sciences Technology Conference VI is a showcase for platform life sciences technologies developed by researchers in the universities, research institutions, and hospitals of Massachusetts and for recently formed Massachusetts companies. The Forum is an opportunity for these companies and researchers to present to an audience of angel investors, venture capitalists and corporate investors. Companies that have presented at our first five Early Stage Life Sciences Conference have raised over $60 million in new investments.

Where: Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115

• MATTO members, academics/staff at MATTO member institutions, MBC members, and Presenters - $90.00
• Non-member - $130.00

Click here to register.

To apply to present please download the Presenter Application Form 2010.
To apply to exhibit please download the Exhibitor Application Form 2010.

Applications due date is February 21, 2010.

If you have any questions regarding presenting or exhibiting please contact Julia Goldberg at jgoldberg@umassp.edu.

For more information about the event please click here or visit www.mattcenter.org.

Save the Date

Location: Boston, MA

The Crossroad for BioTransfer event is a key meeting that brings together the biotechnology business and science communities. For its 3rd edition, the Crossroad for BioTransfer will take place in Boston, MA. For this special edition, the MTTC has joined National Research Council Canada (NRC), Excellerator and Gestion Univalor to present their best licensing opportunities in Life Sciences in the health sector.

The Crossroad for BioTransfer will showcase over 35 licensing opportunities in the health technology portfolios of from the NRC, McGill University, Gestion Univalor and the MTTC. Attendees will be able to schedule meetings with the presenting organizations in order to assess high impact innovations and commercial endeavours.

For this event MTTC will select seven health technologies for licensing to give 10 minutes presentations.  All offered technologies should focus around:

• Novel biopharmaceuticals broadly defined as “the convergence of biotechnologies and pharmaceutical science for the development of medical drugs discovered or produced using biotechnology including innovative chemicals, vaccines, and biologics for therapeutics and diagnostic purposes”; and
• Technology platforms for drug discovery, development and production covering applications such as protein expression, drug delivery and gene markers.

To apply for showcasing your technology at this event please visit www.mattcenter.org/biotransfer2010/present.html or contact Julia Goldberg at jgoldberg@umassp.edu.

For more information, please visit www.biotransfer.ca.